TrialJournal of clinical hypertension (Greenwich, Conn.)2021

Central blood pressure lowering effect of telmisartan-rosuvastatin single-pill combination in hypertensive patients combined with dyslipidemia: A pilot study.

JungMin Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.